Non invasive markers of non-alcoholic steatohepatitis;Nieinwazyjne markery zaawansowania niealkoholowej stłuszczeniowej choroby wa̧troby

Polski Merkuriusz Lekarski

Volumn 25, Issue 146, 2008, Pages 166-170

  Raszeja Wyszomirska, J ^a,b   Miezynska Kurtycz J ^a,b   Marliez, W ^a,b   Lawniczak M ^a,b   Milkiewicz, P ^a,b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Katedry Gastroenterologii

Author keywords

Elastorgaphy; Ferritin; Non alcoholic fatty liver disease (NAFLD); Non alcoholic steatohepatitis (NASH) insulin resistance; Serologic tests of fibrosis

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

BIOPSY; DISEASE COURSE; FATTY LIVER; HUMAN; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; METABOLIC SYNDROME X; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; REVIEW;

BIOLOGICAL MARKERS; BIOPSY; CARCINOMA, HEPATOCELLULAR; CYTOKINES; DISEASE PROGRESSION; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; METABOLIC SYNDROME X; OXIDATIVE STRESS;

EID: 51349107304     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Adams L.A., Sanderson S., Lindor K.D., Angulo P.: The histological course f nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsises. J. Hepatol., 2005, 42, 132-138.
2. Angulo P., Hui J.M., Marchesini G. i wsp.: The NAFLD Fibrosis Score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology, 2007, 45, 846-854.
3. Bonkowsky H.J., Jawaid O., Tortorelli K., i wsp.: Nonalcoholic steatohepatiis and iron: increased prevalence of mutations of the HFE gene in nonalcoholic steatohepatitis. J. Hepatol., 1999, 31, 421-429.
4. Bugianesi E., Manzini P., D'Antico S. i wsp.: Relative contribution of iron burden, HFE mutations and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology, 2004, 39, 179-187.
5. Castera L., Forns X., Alberti A.: non-invasive evaluation of liver fibrosis using transient elastography. J. Hepatol., 2008, 48, 835-847.
6. Chitturi S., Weltman M., Farrell G.C. i wsp.: HFE mutations, hepatic iron and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology, 2002, 36, 142-149.
7. Deguti M.M., Sipahi A.M., Gayotto L.C. i wsp.: Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis. Braz. J. Med Biol Res, 2003, 36, 739-745.
8. Duseja A., Das R., Nanda M. i wsp.: Nonalcoholic steatohepatitis In Asian Indians is neither associated with iron overload nor with HFE gene mutations. World J Gastroenterol, 2005, 11, 393-395.
9. Ellervik Ch. Birgens H., Tybjaerg-Hansen A. i wsp.: Hemochromatosis genotypes and risk of 31 disease endpoint: meta-analyses including 66, 000 cases and 226, 000 controls. Hepatology, 2007, 46, 1071-1080.
10. Facchini F.S., Hua N.W., Stoohs R.A.: Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology, 2002, 122, 931-939.
11. Farrell G.C., Larter C.Z.: Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology, 2006, 43, S99-S112.
12. Fernandez-Real J.M., Lopez-Bermejo A., Ricart W., Iron stores, blood donation and insulin sensitivity and secretion. Clin Chem, 2005, 51, 1201-1205.
13. George D.K., Goldwurm S., MacDonald G.A. i wsp.: Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology, 1998, 114, 311-318.
14. Gutkowski K., Hartleb M.: Non-invasive methods of liver fibrosis assessment: current possibilities and future perpectives. Gastroenterol. Pol., 2007, 14, 5, 325-327.
15. Gutkowski K., Kamińska E., Pluta A.: Rola diagnostyki nieinwazyjnej w ocenie zaawansowania procesu włóknienia wa̧troby. Gastroenterol. Pol., 2007, 14, 5, 363-336.
16. Hui J., Farrell G.C., Kench J.G. i wsp.: High sensitivity CRP protein values do not reliably predict the severity of histoligic change in NAFLD. Hepatology, 2004, 39, 1458-1459.
17. Jiang R., Manson J.E., Meigs J.B. i wsp.: Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA, 2004, 291, 711-717.
18. Kaneda H., Hashimoto E., Yatsuji S. i wsp.: Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol, 2006, 21, 1459-1465.
19. Lonardo A., Carani C., Carulli N., Loria P.: "Endocrine NAFLD" a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J. Hepatol., 2006, 44, 1196-1207.
20. Machado M., Cortez-Pinto H.: NASH, insulin resistance and iron. Liver International, 2006, 26, 1159-1162.
21. Nelson J.E., Bhattacharya R., Lindor K. i wsp.: HFE 282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology, 2007, 46, 723-729.
22. Park S.H., Kim B.I., Yun J.W. i wsp.: Insulin resistance and C-reactive protein as independent risk factor for non-alcoholic fatty liver disease in non obese Asian men. J Gastroenterol Hepatol, 2004, 19, 694-698.
23. Salonen J.T., Tuomainen T.P., Nyyssonen K. i wsp.: Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ, 1998, 317, 727.
24. Shimada M., Kawahara H., Ozaki K. i wsp.: Usefulness of a combined evolution of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis. Am. J. Gastroenterol., 2007, 102, 1931-1938.
25. Trombini P., Piperno A.: Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons. J. Hepatol., 2007, 46, 549-552.
26. Videla L.A., Fernandez V., Tapia G. i wsp.: Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells. Biometals, 2003, 16, 103-111.
27. Wrede C.E., Buettner R., Bollheimer L.C. i wsp.: Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur. J. Endocrinol., 2006, 154, 330-340.